FDCP
LLY icon

Foster Dykema Cabot & Partners’s Eli Lilly LLY Stock Holding History

Foster Dykema Cabot & Partners’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33.6M Sell
28,025
-48
-0.2% -$49K 1.95% 15
2026
Q1 		$25.8M Sell
28,073
-44
-0.2% -$44.6K 1.64% 18
2025
Q4 		$30.2M Sell
28,117
-1,962
-7% -$1.88M 1.86% 14
2025
Q3 		$22.9M Sell
30,079
-120
-0.4% -$89.3K 1.51% 24
2025
Q2 		$23.5M Sell
30,199
-824
-3% -$640K 1.66% 21
2025
Q1 		$25.6M Sell
31,023
-2,537
-8% -$2.11M 2.06% 17
2024
Q4 		$25.9M Sell
33,560
-9,163
-21% -$7.59M 2.02% 16
2024
Q3 		$37.9M Sell
42,723
-1,016
-2% -$913K 3.18% 7
2024
Q2 		$39.6M Sell
43,739
-212
-0.5% -$170K 3.54% 6
2024
Q1 		$34.2M Sell
43,951
-5,497
-11% -$3.91M 3.18% 6
2023
Q4 		$28.8M Buy
+49,448
New +$28.9M 3.05% 6

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Foster Dykema Cabot & Partners's LLY Position: Q2 2026 in Review

Foster Dykema Cabot & Partners reduced its Eli Lilly (LLY) stake by 0.17% in Q2 2026, selling an estimated $49K and leaving 28,025 shares worth $33.6M. The position accounts for 1.95% of the portfolio, ranked #15.

Foster Dykema Cabot & Partners first reported a position in LLY in Q4 2023 and has held it in 11 quarters since. The position peaked at $39.6M in Q2 2024. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Foster Dykema Cabot & Partners held 28,025 shares of Eli Lilly worth $33.6M as of Q2 2026.
  • Foster Dykema Cabot & Partners sold 48 Eli Lilly shares in Q2 2026, an estimated $49K.
  • Eli Lilly made up 1.95% of Foster Dykema Cabot & Partners's portfolio in Q2 2026, its #15 holding.
  • Foster Dykema Cabot & Partners first reported a position in Eli Lilly in Q4 2023 and has held it in 11 quarters since.
  • Foster Dykema Cabot & Partners's Eli Lilly position peaked at $39.6M in Q2 2024.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Foster Dykema Cabot & Partners's 13F filing for Q2 2026, filed 11 Aug 2026.